Skip to main content
SpringerLink
Log in

Specific symptom burden in patients with chronic myeloproliferative neoplasms and chronic kidney disease

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

Data are available from the corresponding author upon reasonable request.

References

  1. Lucijanic M, Krecak I, Kusec R (2002) Renal disease associated with chronic myeloproliferative neoplasms. Expert Rev Hematol 15(2):93–96

  2. Lucijanic M, Galusic D, Krecak I, Sedinic M, Holik H, Perisa V, Moric Peric M, Zekanovic I, Stoos-Veic T, Kusec R (2020) Reduced renal function strongly affects survival and thrombosis in patients with myelofibrosis. Ann Hematol 99(12):2779–2785

  3. Krečak I, Holik H, Martina MP, Zekanović I, Coha B, Gverić-Krečak V (2020) Chronic kidney disease could be a risk factor for thrombosis in essential thrombocythemia and polycythemia vera. Int J Hematol 112(3):377–384

    Article  PubMed  Google Scholar 

  4. Harrison CN, Koschmieder S, Foltz L, Guglielmelli P, Flindt T, Koehler M, Mathias J, Komatsu N, Boothroyd RN, Spierer A, Perez Ronco J, Taylor-Stokes G, Waller J, Mesa RA (2017) The impact of myeloproliferative neoplasms (MPNs) on patient quality of life and productivity: results from the international MPN Landmark survey. Ann Hematol 96(10):1653–1665

    Article  PubMed  PubMed Central  Google Scholar 

  5. Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391–2405

    Article  CAS  PubMed  Google Scholar 

  6. Emanuel RM, Dueck AC, Geyer HL, Kiladjian JJ, Slot S, Zweegman S, te Boekhorst PA, Commandeur S, Schouten HC, Sackmann F, Kerguelen Fuentes A, Hernández-Maraver D, Pahl HL, Griesshammer M, Stegelmann F, Doehner K, Lehmann T, Bonatz K, Reiter A, Boyer F, Etienne G, Ianotto JC, Ranta D, Roy L, Cahn JY, Harrison CN, Radia D, Muxi P, Maldonado N, Besses C, Cervantes F, Johansson PL, Barbui T, Barosi G, Vannucchi AM, Passamonti F, Andreasson B, Ferrari ML, Rambaldi A, Samuelsson J, Birgegard G, Tefferi A, Mesa RA (2012) Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNs. J Clin Oncol 30(33):4098–4103

    Article  PubMed  PubMed Central  Google Scholar 

  7. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461–70

    Article  CAS  PubMed  Google Scholar 

  8. Levin A, Stevens PE (2014) Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int 85(1):49–61

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Dr. Josip Benčević General Hospital, Slavonski Brod, Croatia

    Hrvoje Holik

  2. School of Medicine, University of Osijek, Osijek, Croatia

    Hrvoje Holik

  3. University Hospital Dubrava, Zagreb, Croatia

    Marko Lucijanic

  4. School of Medicine, University of Zagreb, Zagreb, Croatia

    Marko Lucijanic

  5. Department of Internal Medicine, General Hospital of Šibenik-Knin County, Stjepana Radića 83, 22000, Šibenik, Croatia

    Ivan Krecak

  6. School of Medicine, University of Rijeka, Rijeka, Croatia

    Ivan Krecak

Authors
  1. Hrvoje Holik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marko Lucijanic
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ivan Krecak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ivan Krecak.

Ethics declarations

Ethics approval

The study was performed in accordance with the Declaration of Helsinki and was approved by the Ethical Committees from both participating centers (Dr. Josip Bencevic General Hospital Slavonski Brod and General Hospital Sibenik). All patients included in the study provided written informed consent.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Holik, H., Lucijanic, M. & Krecak, I. Specific symptom burden in patients with chronic myeloproliferative neoplasms and chronic kidney disease. Ann Hematol 102, 1963–1965 (2023). https://doi.org/10.1007/s00277-023-05296-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05296-1

Search

Navigation